levothyroxine sodium
- Product NDC
- 68788-7689
- 11-digit product format
- 687887689
- Labeler code
- 68788
- Product ID
- 68788-7689_19da1322-c3d0-4527-acce-95766b7e2dc7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- NDA021116
- Marketing category
- NDA
- Marketing start
- 2020-04-01
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 125 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- levothyroxine sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 125 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966224 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7689-3 | 68788768903 | 30 TABLET in 1 BOTTLE (68788-7689-3) | 30 tablet | 2020-04-01 | 0000-00-00 | No | No | Current |
| 68788-7689-9 | 68788768909 | 90 TABLET in 1 BOTTLE (68788-7689-9) | 90 tablet | 2020-04-01 | 0000-00-00 | No | No | Current |